Vaxxas Initiates Program With Merck to Optimize Delivery of Next Generation Vaccines Utilizing Novel Mechanism for Immune System Activation

You may also like

10 October 2021

Blade Therapeutics Mourns the Passing of General Counsel and Secretary Alan C. Mendelson

29 January 2014

Scale Investment in Paloma

12 January 2021

Clinical Genomics Announces Nationwide Expansion of Patient Access to COLVERA®

19 February 2017

Find-Me Technologies Strengthens the Board in Readiness for Rapid Growth

Announcement, Media Release

04 February 2018

Find-me appoints Rachel Boden as new CEO

15 December 2015

OneVentures commits $3M to launch Australian wearable technology innovation for global dementia market

View All

Ventured. Gained.

Subscribe to our Newsletter for the latest updates from 1V.

decor decor decor
decor decor decor decor decor